| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Ryan H. Saadi is Chief Executive Officer at TVGN. Ryan H. Saadi's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $69.3M at current prices.
The TVGN filings lean toward selling, a net 1,435,599 shares.
Ryan H. Saadi has 9 Form 4 filings on record from February 2024 to September 2026, all as Chief Executive Officer at Tevogen Bio (TVGN), 2024–2026.
The 11 reported transactions were 6 stock awards, 3 gifts, 1 open-market sale and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $2K and 1 sale worth about $1.8M.
The only open-market purchase was 2,607 shares of TVGN at an average $0.77 on June 5, 2024, about $2K. Twelve months later TVGN was up 82%.
The only open-market sale was 1,438,206 shares of TVGN at an average $1.23 on June 9, 2025, about $1.8M. Twelve months later TVGN was up 877%.